A Minnesota judge dismissed a class action lawsuit alleging securities fraud related to insulin pumps made by Medtronic (NYSE ...
13hon MSN
Sanofi (SNY) Caps Cost of Any Insulin Product at $35 per Month; Berenberg Reaffirms Its Buy Rating
With significant upside potential, Sanofi (NASDAQ:SNY) secures a spot on our list of the 12 Best Widow and Orphan Stocks to ...
Remission of prediabetes can occur even without weight loss, protecting against type 2 diabetes in up to 22% of individuals.
Sanofi plans to make insulin more affordable and accessible for all patients next year. The company has taken action to fix insulin prices at $35 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results